ID   SFRP3_HUMAN             Reviewed;         325 AA.
AC   Q92765; O00181; Q99686;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   21-MAR-2012, entry version 112.
DE   RecName: Full=Secreted frizzled-related protein 3;
DE            Short=sFRP-3;
DE   AltName: Full=Frezzled;
DE   AltName: Full=Fritz;
DE   AltName: Full=Frizzled-related protein 1;
DE   AltName: Full=FrzB-1;
DE   Flags: Precursor;
GN   Name=FRZB; Synonyms=FIZ, FRE, FRP, FRZB1, SFRP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   MEDLINE=96421609; PubMed=8824257; DOI=10.1074/jbc.271.42.26131;
RA   Hoang B., Moos M. Jr., Vukicevic S., Luyten F.P.;
RT   "Primary structure and tissue distribution of FRZB, a novel protein
RT   related to Drosophila frizzled, suggest a role in skeletal
RT   morphogenesis.";
RL   J. Biol. Chem. 271:26131-26137(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=97321551; PubMed=9178261; DOI=10.1016/S0925-4773(97)00035-X;
RA   Mayr T., Deutsch U., Kuehl M., Drexler H.C.A., Lottspeich F.,
RA   Deutzmann R., Wedlich D., Risau W.;
RT   "Fritz: a secreted frizzled-related protein that inhibits Wnt
RT   activity.";
RL   Mech. Dev. 63:109-125(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Embryo;
RX   MEDLINE=97236495; PubMed=9118218; DOI=10.1016/S0092-8674(00)81921-2;
RA   Leyns L., Bouwmeester T., Kim S.-H., Piccolo S., de Robertis E.M.;
RT   "Frzb-1 is a secreted antagonist of Wnt signaling expressed in the
RT   Spemann organizer.";
RL   Cell 88:747-756(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 33-47.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [7]
RP   VARIANT HIP OA SUSCEPTIBILITY GLY-324, AND VARIANT TRP-200.
RX   PubMed=15210948; DOI=10.1073/pnas.0403456101;
RA   Loughlin J., Dowling B., Chapman K., Marcelline L., Mustafa Z.,
RA   Southam L., Ferreira A., Ciesielski C., Carson D.A., Corr M.;
RT   "Functional variants within the secreted frizzled-related protein 3
RT   gene are associated with hip osteoarthritis in females.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:9757-9762(2004).
CC   -!- FUNCTION: Soluble frizzled-related proteins (sFRPS) function as
CC       modulators of Wnt signaling through direct interaction with Wnts.
CC       They have a role in regulating cell growth and differentiation in
CC       specific cell types. SFRP3/FRZB appears to be involved in limb
CC       skeletogenesis. Antagonist of Wnt8 signaling. Regulates
CC       chondrocyte maturation and long bone development.
CC   -!- SUBCELLULAR LOCATION: Secreted (Probable).
CC   -!- TISSUE SPECIFICITY: Expressed primarily in the cartilaginous cores
CC       of the long bone during embryonic and fetal development and in the
CC       appendicular skeleton (6-13 weeks). At 13 weeks of gestation,
CC       transcripts were present in early chondroblasts of the tarsal
CC       bones of the foot, the carpal bones of the hands and the epiphysis
CC       of long bones. Highly expressed in placenta and heart, followed by
CC       brain, skeletal muscle, kidney and pancreas. Weakly expressed in
CC       lung and liver.
CC   -!- DOMAIN: The FZ domain is involved in binding with Wnt ligands (By
CC       similarity).
CC   -!- DISEASE: Defects in FRZB are associated with susceptibility to
CC       osteoarthritis type 1(OS1) [MIM:165720]. Osteoarthritis is a
CC       degenerative disease of the joints characterized by degradation of
CC       the hyaline articular cartilage and remodeling of the subchondral
CC       bone with sclerosis. Clinical symptoms include pain and joint
CC       stiffness often leading to significant disability and joint
CC       replacement.
CC   -!- SIMILARITY: Belongs to the secreted frizzled-related protein
CC       (sFRP) family.
CC   -!- SIMILARITY: Contains 1 FZ (frizzled) domain.
CC   -!- SIMILARITY: Contains 1 NTR domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U24163; AAC50736.1; -; mRNA.
DR   EMBL; U91903; AAB51298.1; -; mRNA.
DR   EMBL; U68057; AAC51217.1; -; mRNA.
DR   EMBL; BT019883; AAV38686.1; -; mRNA.
DR   EMBL; BC027855; AAH27855.1; -; mRNA.
DR   IPI; IPI00294650; -.
DR   RefSeq; NP_001454.2; NM_001463.3.
DR   UniGene; Hs.128453; -.
DR   ProteinModelPortal; Q92765; -.
DR   SMR; Q92765; 33-157, 167-278.
DR   IntAct; Q92765; 1.
DR   STRING; Q92765; -.
DR   DMDM; 14194748; -.
DR   PRIDE; Q92765; -.
DR   DNASU; 2487; -.
DR   Ensembl; ENST00000295113; ENSP00000295113; ENSG00000162998.
DR   GeneID; 2487; -.
DR   KEGG; hsa:2487; -.
DR   UCSC; uc002upa.1; human.
DR   CTD; 2487; -.
DR   GeneCards; GC02M183662; -.
DR   H-InvDB; HIX0002650; -.
DR   HGNC; HGNC:3959; FRZB.
DR   HPA; CAB009249; -.
DR   MIM; 165720; phenotype.
DR   MIM; 605083; gene.
DR   neXtProt; NX_Q92765; -.
DR   PharmGKB; PA28377; -.
DR   eggNOG; NOG304384; -.
DR   GeneTree; ENSGT00560000076776; -.
DR   HOGENOM; HBG403122; -.
DR   HOVERGEN; HBG070536; -.
DR   InParanoid; Q92765; -.
DR   OMA; EEYLIMG; -.
DR   OrthoDB; EOG4B8JDD; -.
DR   PhylomeDB; Q92765; -.
DR   NextBio; 9825; -.
DR   ArrayExpress; Q92765; -.
DR   Bgee; Q92765; -.
DR   CleanEx; HS_FRZB; -.
DR   Genevestigator; Q92765; -.
DR   GermOnline; ENSG00000162998; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IBA:RefGenome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0030165; F:PDZ domain binding; IBA:RefGenome.
DR   GO; GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome.
DR   GO; GO:0017147; F:Wnt-protein binding; ISS:UniProtKB.
DR   GO; GO:0007420; P:brain development; IBA:RefGenome.
DR   GO; GO:0090103; P:cochlea morphogenesis; IBA:RefGenome.
DR   GO; GO:0008406; P:gonad development; IBA:RefGenome.
DR   GO; GO:0060056; P:mammary gland involution; IBA:RefGenome.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0061037; P:negative regulation of cartilage development; IBA:RefGenome.
DR   GO; GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0070367; P:negative regulation of hepatocyte differentiation; IBA:RefGenome.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IGI:MGI.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; IDA:MGI.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   GO; GO:0001944; P:vasculature development; IBA:RefGenome.
DR   GO; GO:0016055; P:Wnt receptor signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR015526; Frizzled-related.
DR   InterPro; IPR020067; Frizzled_dom.
DR   InterPro; IPR001134; Netrin_domain.
DR   InterPro; IPR018933; Netrin_module_non-TIMP.
DR   InterPro; IPR008993; TIMP-like_OB-fold.
DR   Gene3D; G3DSA:1.10.2000.10; Frizzled_Cys-rich; 1.
DR   PANTHER; PTHR11309; Fz_related; 1.
DR   Pfam; PF01392; Fz; 1.
DR   Pfam; PF01759; NTR; 1.
DR   SMART; SM00643; C345C; 1.
DR   SMART; SM00063; FRI; 1.
DR   SUPFAM; SSF63501; Frizzled_Cys-rich; 1.
DR   SUPFAM; SSF50242; TIMP_like; 1.
DR   PROSITE; PS50038; FZ; 1.
DR   PROSITE; PS50189; NTR; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Differentiation;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Polymorphism; Reference proteome; Secreted; Signal;
KW   Wnt signaling pathway.
FT   SIGNAL        1     32
FT   CHAIN        33    325       Secreted frizzled-related protein 3.
FT                                /FTId=PRO_0000032546.
FT   DOMAIN       33    150       FZ.
FT   DOMAIN      178    298       NTR.
FT   COMPBIAS    301    318       Ser-rich.
FT   CARBOHYD     49     49       N-linked (GlcNAc...) (Potential).
FT   DISULFID     35     96       By similarity.
FT   DISULFID     43     89       By similarity.
FT   DISULFID     80    119       By similarity.
FT   DISULFID    108    147       By similarity.
FT   DISULFID    112    136       By similarity.
FT   VARIANT     200    200       R -> W (in dbSNP:rs288326).
FT                                /FTId=VAR_021411.
FT   VARIANT     324    324       R -> G (in hip OA susceptibility; has
FT                                diminished ability to antagonize Wnt
FT                                signaling, in vitro; dbSNP:rs7775).
FT                                /FTId=VAR_014862.
FT   CONFLICT     63     63       A -> D (in Ref. 2; AAB51298).
FT   CONFLICT    106    106       K -> N (in Ref. 1; AAC50736).
SQ   SEQUENCE   325 AA;  36254 MW;  8337C51BBA9A4B07 CRC64;
     MVCGSPGGML LLRAGLLALA ALCLLRVPGA RAAACEPVRI PLCKSLPWNM TKMPNHLHHS
     TQANAILAIE QFEGLLGTHC SPDLLFFLCA MYAPICTIDF QHEPIKPCKS VCERARQGCE
     PILIKYRHSW PENLACEELP VYDRGVCISP EAIVTADGAD FPMDSSNGNC RGASSERCKC
     KPIRATQKTY FRNNYNYVIR AKVKEIKTKC HDVTAVVEVK EILKSSLVNI PRDTVNLYTS
     SGCLCPPLNV NEEYIIMGYE DEERSRLLLV EGSIAEKWKD RLGKKVKRWD MKLRHLGLSK
     SDSSNSDSTQ SQKSGRNSNP RQARN
//
